Novel imaging techniques in melanoma.

No abstract is available for this paper.

• Publication year

  2006

• Venue

  Surgical Oncology Clinics of North America

• Publication date

  2006-04-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/J.SOC.2005.12.009PMID 16632214
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Interferon Alfa-2b Adjuvant Therapy of High-Risk Resected Cutaneous Melanoma: The Eastern Cooperative Oncology Group Trial EST 1684

  2023cited by this paper
• Impact of 2-Deoxy-2[F-18]Fluoro-d-Glucose Positron Emission Tomography on the Management of Patients with Advanced Melanoma

  2005cited by this paper
• A plea for the elective inclusion of the brain in routine whole-body FDG PET

  2005cited by this paper
• Evaluation of extensive initial staging procedure in intermediate/high‐risk melanoma patients

  2005cited by this paper
• High constant incidence rates of second cutaneous melanomas

  2005cited by this paper
• Prognostic factors in localized invasive cutaneous melanoma: high value of mitotic rate, vascular invasion and microscopic satellitosis

  2005cited by this paper
• Concurrent PET/CT with an integrated imaging system: intersociety dialogue from the joint working group of the American College of Radiology, the Society of Nuclear Medicine, and the Society of Computed Body Tomography and Magnetic Resonance.

  2005cited by this paper
• Sentinel lymphadenectomy does not increase the incidence of in-transit metastases in primary melanoma.

  2005cited by this paper
• CT in PET/CT: essential features of interpretation.

  2005cited by this paper
• The risk of in-transit melanoma metastasis depends on tumor biology and not the surgical approach to regional lymph nodes.

  2005cited by this paper
• Hybrid SPECT/CT: a new era for SPECT imaging?

  2005cited by this paper
• ESMO Minimum Clinical Recommendations for diagnosis, treatment and follow-up of cutaneous malignant melanoma.

  2005cited by this paper
• Normal values of serum S-100B predict prolonged survival for stage IV melanoma patients.

  2005cited by this paper
• Detection of unexpected additional primary malignancies with PET/CT.

  2005cited by this paper
• Melanoma: treatment guidelines for patients (Part 1).

  2005cited by this paper
• Signaling networks in cutaneous melanoma metastasis identified by complementary DNA microarrays.

  2005cited by this paper
• Inefficacy of F‐18 fluorodeoxy‐D‐glucose‐positron emission tomography scans for initial evaluation in early‐stage cutaneous melanoma

  2005cited by this paper
• Cancer Statistics, 2005

  2005cited by this paper
• Fluorodeoxyglucose-PET in the management of malignant melanoma.

  2005cited by this paper
• Significance of incidental 18F-FDG accumulations in the gastrointestinal tract in PET/CT: correlation with endoscopic and histopathologic results.

  2004cited by this paper
• PET/CT today and tomorrow.

  2004cited by this paper
• PET imaging in gynecologic malignancies.

  2004cited by this paper
• Whole-body fluorine-18 fluordeoxyglucose positron emission tomography/computed tomography (FDG-PET/CT) in staging of advanced uveal melanoma.

  2004cited by this paper
• FDG PET and PET/CT imaging in lymphoma and melanoma.

  2004cited by this paper
• A Prospective Analysis of Positron Emission Tomography and Conventional Imaging for Detection of Stage IV Metastatic Melanoma in Patients Undergoing Metastasectomy

  2004cited by this paper
• Impact of 18F-Fluoro-2-Deoxy-D-Glucose Positron Emission Tomography (FDG-PET) in Patients with Biochemical Evidence of Recurrent or Residual Medullary Thyroid Cancer

  2004cited by this paper
• Is the identification of in-transit sentinel lymph nodes in malignant melanoma patients really necessary?

  2004cited by this paper
• Positron emission tomography is not useful in detecting metastasis in the sentinel lymph node in patients with primary malignant melanoma stage I and II

  2004cited by this paper
• The natural course of cutaneous melanoma

  2004cited by this paper
• The role of PET imaging in lymphoma

  2004cited by this paper
• Selective lymphadenectomy in sentinel node-positive patients may increase the risk of local/in-transit recurrence in malignant melanoma.

  2004cited by this paper
• Imaging of esophageal and gastric cancer.

  2004cited by this paper
• Sentinel Node Biopsy in Head and Neck Cancer: Preliminary Results of a Multicenter Trial

  2004cited by this paper
• Positron-emission tomography in prognostic and therapeutic assessment of lung cancer: systematic review.

  2004cited by this paper
• PET/CT in oncology: integration into clinical management of lymphoma, melanoma, and gastrointestinal malignancies.

  2004cited by this paper
• Routine imaging of asymptomatic melanoma patients with metastasis to sentinel lymph nodes rarely identifies systemic disease.

  2004cited by this paper
• FDG PET and tumour markers in the diagnosis of recurrent and metastatic breast cancer

  2004cited by this paper
• Potentially Curative Resection for Locoregional Recurrence of Colorectal Cancer

  2004cited by this paper
• The Hottest Sentinel Lymph Node is Not Always the Positive Node

  2004cited by this paper
• PET and brain tumor image fusion.

  2004cited by this paper
• Is 18F-FDG PET more accurate than standard diagnostic procedures in the detection of suspected recurrent melanoma?

  2004cited by this paper
• PET imaging in assessing gastrointestinal tumors.

  2004cited by this paper
• Systematic review of the staging performance of 18F-fluorodeoxyglucose positron emission tomography in esophageal cancer.

  2004cited by this paper
• Diagnosing melanoma patients entering American Joint Committee on Cancer stage IV, C-reactive protein in serum is superior to lactate dehydrogenase

  2004cited by this paper
• An Evidence‐based Staging System for Cutaneous Melanoma 1

  2004cited by this paper
• Role of FDG-PET in the diagnosis and treatment of colorectal liver metastases

  2004cited by this paper
• Malignant melanoma of the skin - not a sunshine story!

  2004cited by this paper
• Lymphoscintigraphy for sentinel node mapping using a hybrid SPECT/CT system.

  2003cited by this paper
• SPECT/CT in tumor imaging: technical aspects and clinical applications.

  2003cited by this paper
• Body site of cutaneous malignant melanoma – a study on patients with hereditary and multiple sporadic tumours

  2003cited by this paper
• Schildwächterlymphknotenexzision (SLKE) und Positronenemissionstomographie (PET)

  2003cited by this paper
• Fluorodeoxyglucose–Positron Emission Tomography Imaging Versus Sentinel Node Biopsy in the Primary Staging of Melanoma Patients

  2003cited by this paper
• How morphometric analysis of metastatic load predicts the (un)usefulness of PET scanning: the case of lymph node staging in melanoma

  2003cited by this paper
• Medical management of melanoma.

  2003cited by this paper
• Staging of non-small-cell lung cancer with integrated positron-emission tomography and computed tomography.

  2003cited by this paper
• [Sentinel lymph node excision (SLNE) and positron emission tomography in the staging of stage I-II melanoma patients].

  2003cited by this paper
• Malignant melanoma and 18F-FDG-PET: Should the whole body scan include the legs?

  2003cited by this paper
• Fluorodeoxyglucose-positron emission tomography and sentinel lymph node biopsy in staging primary cutaneous melanoma.

  2003cited by this paper
• Prospective evaluation of a follow-up schedule in cutaneous melanoma patients: recommendations for an effective follow-up strategy.

  2003cited by this paper
• Preoperative localization and radioguided parathyroid surgery.

  2003cited by this paper
• Melanoma patients evaluated by four different positron emission tomography reconstruction techniques

  2003cited by this paper
• Patterns of lymphatic drainage from the skin in patients with melanoma.

  2003cited by this paper
• 3'-18F-fluoro-3'-deoxy-L-thymidine: a new tracer for staging metastatic melanoma?

  2003cited by this paper
• The Role of Fluorine-18 Deoxyglucose Positron Emission Tomography in the Management of Patients With Metastatic Melanoma: Impact on Surgical Decision Making

  2003cited by this paper
• Optimization of the Gamma Probe-Guided Parathyroidectomy

  2003cited by this paper
• ESMO Minimum Clinical Recommendations for diagnosis, treatment and follow-up of cutaneous malignant melanoma.

  2003cited by this paper
• Radioguided sentinel lymph node biopsy in malignant cutaneous melanoma.

  2002cited by this paper
• Prolonged survival after complete resection of disseminated melanoma and active immunotherapy with a therapeutic cancer vaccine.

  2002cited by this paper
• Lymphoscintigraphy in cutaneous melanoma: a total body atlas of sentinel node mapping.

  2002cited by this paper
• Primary staging and follow-up in melanoma patients – monocenter evaluation of methods, costs and patient survival

  2002cited by this paper
• Procedure guideline for lymphoscintigraphy and the use of intraoperative gamma probe for sentinel lymph node localization in melanoma of intermediate thickness 1.0.

  2002cited by this paper
• Sentinel Lymph Node Detection by Lymphoscintigraphy in Malignant Melanoma

  2002cited by this paper
• Molecular lymphatic mapping of the sentinel lymph node.

  2002cited by this paper
• Clinical and Laboratory Investigations Metastatic pathways and time courses in the orderly progression of cutaneous melanoma

  2002cited by this paper
• Reproducibility and clinical value of 18F-fluorodeoxyglucose positron emission tomography in recurrent melanoma

  2002cited by this paper
• A rational approach to the follow-up of melanoma patients.

  2002cited by this paper
• Unpredictability of lymphatic drainage patterns in melanoma patients

  2002cited by this paper
• Staging of regional nodes in AJCC stage I and II melanoma: 18FDG PET imaging versus sentinel node detection.

  2002cited by this paper
• Positron emission tomography is superior to computed tomography for metastatic detection in melanoma patients

  2002cited by this paper
• Pattern and incidence of first site recurrences following sentinel node procedure in melanoma patients

  2002cited by this paper
• Evaluation of high-risk melanoma: comparison of [18F]FDG PET and high-dose 67Ga SPET

  2002cited by this paper
• 18-FDG PET scan in the staging of recurrent melanoma: additional value and therapeutic impact

  2002cited by this paper
• The surgical management of metastatic melanoma

  2002cited by this paper
• FDG–PET sensitivity for melanoma lymph node metastases is dependent on tumor volume

  2001cited by this paper
• Specific targeting, biodistribution, and lack of immunogenicity of chimeric anti-GD3 monoclonal antibody KM871 in patients with metastatic melanoma: results of a phase I trial.

  2001cited by this paper
• Comparison of positron emission tomography scanning and sentinel node biopsy in the detection of micrometastases of primary cutaneous malignant melanoma.

  2001cited by this paper
• S100 beta is a more reliable tumor marker in peripheral blood for patients with newly occurred melanoma metastases compared with MIA, albumin and lactate-dehydrogenase.

  2001cited by this paper
• Concurrent induction of lymphangiogenesis, angiogenesis, and macrophage recruitment by vascular endothelial growth factor-C in melanoma.

  2001cited by this paper
• Therapeutic approach in adrenal melanoma. Review of the literature

  2001cited by this paper
• Final version of the American Joint Committee on Cancer staging system for cutaneous melanoma.

  2001cited by this paper
• Application of an [(18)F]fluorodeoxyglucose-sensitive probe for the intraoperative detection of malignancy.

  2001cited by this paper
• Systematic review of the diagnostic accuracy of 18F‐fluorodeoxyglucose positron emission tomography in melanoma patients

  2001cited by this paper
• [Therapeutic approach in adrenal melanoma. Review of the literature].

  2001cited by this paper
• The Use of Lymphoscintigraphy and PET in the Management of Head and Neck Melanoma

  2001cited by this paper
• Prognostic factors analysis of 17,600 melanoma patients: validation of the American Joint Committee on Cancer melanoma staging system.

  2001cited by this paper
• Use of fluorine-18 fluorodeoxyglucose positron emission tomography in the detection of silent metastases from malignant melanoma

  2000cited by this paper
• Positron emission tomography scanning in malignant melanoma.

  2000cited by this paper
• Prognostic significance of an increased number of micrometastatic tumor cells in the bone marrow of patients with first recurrence of breast carcinoma

  2000cited by this paper
• Prognostic factors in metastatic melanoma: a pooled analysis of Eastern Cooperative Oncology Group trials.

  2000cited by this paper
• Surgical therapy for distant metastases of malignant melanoma

  2000cited by this paper

• Recent Advancement in the Management of Skin Melanoma

  2024cites this paper
• The rational of Cloquet lymph node as a sentinel lymph node in iliac dissection in lower limb melanoma

  2023cites this paper
• Unlocking the Hidden Depths: Multi-Modal Integration of Imaging Mass Spectrometry-Based and Molecular Imaging Techniques

  2023cites this paper
• Intussusception on melanoma metastasis: A rare condition

  2020cites this paper
• Nestin is highly expressed in advanced-stage melanomas and neurotized nevi.

  2013cites this paper
• Determination of Melanoma Lateral and Depth Margins: Potential for Treatment Planning and Five-Year Survival Rate

  2011cites this paper
• State of the art in non‐invasive imaging of cutaneous melanoma

  2011cites this paper
• [Intussusception on multiple metastases of malignant melanoma].

  2011cites this paper
• RANK is expressed in metastatic melanoma and highly upregulated on melanoma-initiating cells.

  2011cites this paper
• Invagination intestinale sur mtastases multiples dun mlanome malin

  2011cites this paper
• Chapter 141 – Tumors

  2010cites this paper
• Cost-effectiveness analysis of FDG PET-CT in the management of pulmonary metastases from malignant melanoma

  2010cites this paper
• CLÍNICA DE PRESENTACION DE MELANOMA MALIGNO: A PROPÓSITO DE UN CASO MALIGNANT MELANOMA: CLINICAL PRESENTATION, REPORT OF A CASE

  2010cites this paper
• Metastatic cutaneous malignant melanoma: Spectrum of imaging findings and the role of multimodality imaging

  2009cites this paper
• Review of evidence-based support for pretreatment imaging in melanoma.

  2009cites this paper
• Economic evaluation of positron emission tomography : activity-based costing and modelling techniques in malignant melanoma

  2009cites this paper
• Metástasis de melanoma maligno a intestino delgado: reporte de un caso

  2008cites this paper
• Role of PET in the initial staging of cutaneous malignant melanoma: systematic review.

  2008cites this paper
• Radiology of soft tissue tumors including melanoma.

  2008cites this paper
• Oncolytic virotherapy for malignant melanoma with herpes simplex virus type 1 mutant HF10.

  2008cites this paper
• Melanoma cutâneo: doença curável? Revisão de literatura e apresentação de um organograma de investigação e tratamento

  2008cites this paper
• Preoperative imaging for metastasectomy.

  2007cites this paper
• Surgical management of the groin lymph nodes in melanoma in the era of sentinel lymph node dissection.

  2006cites this paper